These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 11801630
1. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. Greenwald RJ, McAdam AJ, Van der Woude D, Satoskar AR, Sharpe AH. J Immunol; 2002 Feb 01; 168(3):991-5. PubMed ID: 11801630 [Abstract] [Full Text] [Related]
2. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, Duke-Cohan JS, Chernova T, Malenkovich N, Jabs C, Kuchroo VK, Ling V, Collins M, Sharpe AH, Freeman GJ. J Immunol; 2000 Nov 01; 165(9):5035-40. PubMed ID: 11046032 [Abstract] [Full Text] [Related]
3. The inducible costimulator plays the major costimulatory role in humoral immune responses in the absence of CD28. Suh WK, Tafuri A, Berg-Brown NN, Shahinian A, Plyte S, Duncan GS, Okada H, Wakeham A, Odermatt B, Ohashi PS, Mak TW. J Immunol; 2004 May 15; 172(10):5917-23. PubMed ID: 15128772 [Abstract] [Full Text] [Related]
4. B7RP-1-ICOS interactions are required for optimal infection-induced expansion of CD4+ Th1 and Th2 responses. Wilson EH, Zaph C, Mohrs M, Welcher A, Siu J, Artis D, Hunter CA. J Immunol; 2006 Aug 15; 177(4):2365-72. PubMed ID: 16887998 [Abstract] [Full Text] [Related]
9. Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells. Smith KM, Brewer JM, Webb P, Coyle AJ, Gutierrez-Ramos C, Garside P. J Immunol; 2003 Mar 01; 170(5):2310-5. PubMed ID: 12594252 [Abstract] [Full Text] [Related]
11. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos JC, Coyle AJ. Nat Immunol; 2001 Jul 01; 2(7):597-604. PubMed ID: 11429543 [Abstract] [Full Text] [Related]
12. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. Stamm LM, Räisänen-Sokolowski A, Okano M, Russell ME, David JR, Satoskar AR. J Immunol; 1998 Dec 01; 161(11):6180-8. PubMed ID: 9834104 [Abstract] [Full Text] [Related]
14. ICOS+ Th cells produce distinct cytokines in different mucosal immune responses. Bonhagen K, Liesenfeld O, Stadecker MJ, Hutloff A, Erb K, Coyle AJ, Lipp M, Kroczek RA, Kamradt T. Eur J Immunol; 2003 Feb 01; 33(2):392-401. PubMed ID: 12645936 [Abstract] [Full Text] [Related]
16. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Tuladhar R, Oghumu S, Dong R, Peterson A, Sharpe AH, Satoskar AR. Exp Parasitol; 2015 Jan 01; 148():49-55. PubMed ID: 25447125 [Abstract] [Full Text] [Related]
17. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A, Bates PA, Chance ML, Taylor MJ. Parasit Vectors; 2016 Oct 06; 9(1):532. PubMed ID: 27716391 [Abstract] [Full Text] [Related]
18. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Khayyamian S, Hutloff A, Büchner K, Gräfe M, Henn V, Kroczek RA, Mages HW. Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6198-203. PubMed ID: 11983910 [Abstract] [Full Text] [Related]
19. ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. Wassink L, Vieira PL, Smits HH, Kingsbury GA, Coyle AJ, Kapsenberg ML, Wierenga EA. J Immunol; 2004 Aug 01; 173(3):1779-86. PubMed ID: 15265908 [Abstract] [Full Text] [Related]
20. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. Buxbaum LU, Denise H, Coombs GH, Alexander J, Mottram JC, Scott P. J Immunol; 2003 Oct 01; 171(7):3711-7. PubMed ID: 14500670 [Abstract] [Full Text] [Related] Page: [Next] [New Search]